Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Rohto Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	78,244	77,161	89,210	79,951	72,791	52,964
Cash & Short-Term Investments	78,244	77,161	89,210	79,951	72,791	52,964
Cash Growth	21.30%	-13.51%	11.58%	9.84%	37.44%	16.90%
Receivables	71,799	69,880	69,115	60,656	51,682	47,865
Inventory	63,120	61,580	46,657	41,062	33,527	27,925
Other Current Assets	9,065	9,258	9,777	8,577	6,306	4,317
Total Current Assets	222,228	217,879	214,759	190,246	164,306	133,071
Property, Plant & Equipment	88,859	90,451	68,607	66,182	62,839	49,790
Long-Term Investments	60,908	46,649	43,731	32,629	27,471	27,425
Goodwill	33,022	47,494	2,285	2,564	2,954	4,014
Other Intangible Assets	34,791	8,575	6,932	6,997	6,338	3,521
Long-Term Deferred Tax Assets	-	3,975	3,869	5,371	5,297	4,606
Long-Term Deferred Charges	94	99	-	-	-	-
Other Long-Term Assets	2	2	2	1	2	2
Total Assets	439,904	421,875	346,175	309,677	274,627	225,790
Accounts Payable	22,183	22,056	21,123	18,718	16,269	11,330
Accrued Expenses	21,831	24,364	25,720	24,362	19,354	25,208
Short-Term Debt	20,142	7,035	5,304	4,177	8,033	2,312
Current Income Taxes Payable	5,801	6,963	6,643	6,230	3,185	6,138
Other Current Liabilities	32,320	34,190	28,297	26,675	24,647	11,483
Total Current Liabilities	102,277	94,608	87,087	80,162	71,488	56,471
Long-Term Debt	26,939	43,188	5,190	7,516	13,350	5,787
Pension & Post-Retirement Benefits	1,746	1,770	2,548	3,104	3,332	3,451
Long-Term Deferred Tax Liabilities	-	2,081	1,597	1,173	1,450	639
Other Long-Term Liabilities	16,675	8,789	2,720	2,645	1,177	2,831
Total Liabilities	147,637	150,436	99,142	94,600	90,797	69,179
Common Stock	6,504	6,504	6,504	6,504	6,504	6,504
Additional Paid-In Capital	-	-	4,516	5,292	5,787	5,661
Retained Earnings	244,754	228,442	209,399	184,005	162,195	145,511
Treasury Stock	-9,939	-9,939	-4,939	-4,938	-4,936	-4,936
Comprehensive Income & Other	33,868	35,087	30,843	18,706	8,737	3,167
Total Common Equity	275,187	260,094	246,323	209,569	178,287	155,907
Minority Interest	17,080	11,345	710	5,508	5,543	704
Shareholders' Equity	292,267	271,439	247,033	215,077	183,830	156,611
Total Liabilities & Equity	439,904	421,875	346,175	309,677	274,627	225,790
Total Debt	47,081	50,223	10,494	11,693	21,383	8,099
Net Cash (Debt)	31,163	26,938	78,716	68,258	51,408	44,865
Net Cash Growth	56.08%	-65.78%	15.32%	32.78%	14.58%	18.03%
Net Cash Per Share	135.41	117.69	344.04	298.33	224.69	196.09
Filing Date Shares Outstanding	225.96	225.96	228.14	228.14	228.14	228.14
Total Common Shares Outstanding	225.96	225.96	228.14	228.14	228.14	228.14
Working Capital	119,951	123,271	127,672	110,084	92,818	76,600
Book Value Per Share	1217.83	1151.04	1079.71	918.60	781.48	683.38
Tangible Book Value	207,374	204,025	237,106	200,008	168,995	148,372
Tangible Book Value Per Share	917.73	902.91	1039.31	876.69	740.75	650.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.